首页> 外文期刊>Inside EPA's environmental policy alert >EPA DRAWS DATA QUALITY CHALLENGE OVER KEY ENDOCRINE TESTING METHOD
【24h】

EPA DRAWS DATA QUALITY CHALLENGE OVER KEY ENDOCRINE TESTING METHOD

机译:EPA对主要内分泌检测方法提出了数据质量挑战

获取原文
获取原文并翻译 | 示例
       

摘要

An industry-funded watchdog group, in a just-filed Data Quality Act (DQA) petition, is asking EPA to correct its statements on the validity of a key test for evaluating whether pesticides and other chemicals are endocrine disrupting compounds. If the move is successful, one informed source says, it could call into question the agency's ability to proceed with its endocrine screening program, which Congress has ordered EPA to launch next month. The Center for Regulatory Effectiveness (CRE) July 10 filed its petition with EPA over a frog assay that is a key component of EPA's upcoming endocrine disruptor screening program (EDSP), which is intended to narrow a list of chemicals that require additional testing to determine their endocrine disrupting effects.
机译:在刚刚提交的《数据质量法案》(DQA)请愿书中,一个由行业资助的监督组织正在要求EPA更正其关于评估农药和其他化学物质是否是破坏内分泌的化合物的关键测试的有效性的声明。一位知情人士说,如果此举成功,它可能会对该机构进行内分泌筛查计划的能力提出质疑,国会已下令EPA下令启动这项计划。监管有效性中心(CRE)7月10日向美国环保署(EPA)递交了一份关于青蛙检测的请愿书,该检测是EPA即将进行的内分泌干扰物筛选计划(EDSP)的关键组成部分,该计划旨在缩小需要更多测试以确定的化学物质清单它们的内分泌干扰作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号